| Name | Title | Contact Details |
|---|
For nearly 50 years, Acts Retirement-Life Communities has met the retirement lifestyle and healthcare needs of older adults living in our communities. Our first community opened in 1972 with the vision of a church pastor and his congregation whose goal was to create an environment that offered seniors a rewarding lifestyle and high quality healthcare if ever needed. Today, Acts is the largest not-for-profit owner, operator and developer of continuing care retirement communities (CCRCs) in the United States. Our 26 communities currently serve more than 10,000 residents in nine states. Our vision for Acts is to have The Acts Culture of Loving-Kindness be the basic fiber of our daily practice to meet the needs of those we serve. As we continue to grow, we`re looking for dedicated and compassionate individuals to join our team who help to carry out our mission of serving older adults. We have been able to provide an unparalleled quality of life for our residents by recruiting and hiring great people who understand our vision and strive to be a part of it. We are convinced that the secret to our success is our employees who work as a team each day to make a positive difference in the lives of our residents. It is for this reason that we provide a working environment based on fair employment practices, competitive pay and benefits, career opportunities and other programs designed to help our employee`s achieve their professional goals.
Relmada Therapeutics (OTCQB: RLMD) is a clinical-stage, publicly traded specialty pharmaceutical company developing novel versions of proven drug products together with new chemical entities that potentially address areas of high unmet medical need in the treatment of chronic pain. Relmada has a diversified portfolio of four lead products at various stages of development including d-Methadone (REL-1017) its N-methyl-D-aspartate (NMDA) receptor antagonist for neuropathic pain; topical mepivacaine (REL-1021), its orphan drug designated topical formulation of the local anesthetic mepivacaine; oral buprenorphine (REL-1028) its oral dosage form of the opioid analgesic buprenorphine; and LevoCap ER (REL-1015), its abuse resistant, sustained release dosage form of the opioid analgesic levorphanol. Relmada`s product development efforts are guided by the internationally recognized scientific expertise of our research team. Relmada`s approach is expected to reduce clinical development risks and costs while potentially delivering valuable products in areas of high unmet medical needs.
Get relief today in the Phoenix Area! We treat whiplash, knee, back, shoulder, joint pain and more! No narcotics, no surgery, just relief!
PeproTech is a Rocky Hill, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Indivumed is a Kensington, MD-based company in the Healthcare, Pharmaceuticals, and Biotech sector.